-+ 0.00%
-+ 0.00%
-+ 0.00%

Morgan Stanley Maintains Overweight on CVS Health, Raises Price Target to $93

Benzinga·12/10/2025 13:51:01
Listen to the news
Morgan Stanley analyst Erin Wright maintains CVS Health (NYSE:CVS) with a Overweight and raises the price target from $89 to $93.